12929_2019_579_MOESM2_ESM.pdf (372.89 kB)
MOESM2 of The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
journal contribution
posted on 2019-10-31, 06:02 authored by Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, Aurélie Jonneaux, Ming-Li Chou, Régis Bordet, Luc Buée, Folke Knutson, David Blum, Thierry BurnoufAdditional file 2: Figure S2. Representative histograms of cell viability analysis by flow cytometry (propidium iodide staining) after 24 h. The cells were treated with 5% HPPL + erastin, 5% I-PPL + erastin, 5% I-HPPL +erastin.